
HHS
US cabinet health department overseeing CDC, NIH, FDA and BARDA; the weakest senior public-health roster since 2014.
Last refreshed: 17 May 2026 · Appears in 1 active topic
Does HHS have the bench strength to coordinate a Bundibugyo PHEIC with no permanent CDC director?
Timeline for HHS
Thinnest US health bench faces PHEIC
Pandemics and Biosecurity- Who is in charge of the US government's response to the Ebola outbreak?
- HHS oversees the US response. The Assistant Secretary for Health is Brian Christine, an Alabama urologist confirmed in October 2025. Jay Bhattacharya, NIH Director, concurrently serves as acting CDC Director. No permanent CDC Director, FDA Commissioner, or ASPR head is confirmed. Africa CDC's coordination statement names US CDC as a partner but WHO AFRO's release does not list deployed US personnel.Source: WHO AFRO; Africa CDC; Wikipedia/Senate records
- What agencies does HHS oversee?
- HHS oversees CDC (Centers for Disease Control and Prevention), NIH (National Institutes of Health), FDA (Food and Drug Administration), BARDA (Biomedical Advanced Research and Development Authority), ASPR (Administration for Strategic Preparedness and Response), CMS (Centers for Medicare and Medicaid Services), and HRSA (Health Resources and Services Administration), among others.
- How does the current HHS leadership compare to the 2018 Ebola response?
- In 2018, when CDC ran the Equateur DRC response, the agency had a confirmed CDC Director (Robert Redfield), a confirmed FDA Commissioner, and a confirmed ASPR head simultaneously. Today, none of those three positions has a permanent occupant, and the acting CDC Director is Jay Bhattacharya, a health economist, while the ASH is Brian Christine, a urologist.Source: Briefing analysis; Senate records
Background
The US Department of Health and Human Services (HHS) is the cabinet-level federal department responsible for the country's public health infrastructure. Its principal sub-agencies include the CDC (Centers for Disease Control and Prevention), NIH (National Institutes of Health), FDA (Food and Drug Administration), ASPR (Administration for Strategic Preparedness and Response), and BARDA (Biomedical Advanced Research and Development Authority). HHS's combined budget is approximately $1.8 trillion annually, though biosecurity and preparedness programmes represent a small fraction of that.
In the context of the Bundibugyo PHEIC declared 17 May 2026, HHS has presented a markedly thin senior leadership bench. The position of Assistant Secretary for Health — the second-ranking health official below the Secretary — is occupied by Brian Christine, an Alabama urologist Senate-confirmed in October 2025. Jay Bhattacharya, confirmed as NIH Director in March 2025, concurrently holds the acting CDC Director role. No permanent FDA Commissioner, no permanent ASPR head, and no permanent CDC Director are in post. When CDC ran the 2018 Equateur response, all three positions were confirmed simultaneously.
HHS's response to the PHEIC has consisted of public statements: acting CDC Director Bhattacharya stated CDC has country offices in DRC and Uganda and is committed to providing technical expertise. No named deployed CDC personnel appear in WHO AFRO's coordination release for the Bundibugyo response. The combination of leadership gaps, USAID dismantlement, and an acting CDC Director operating outside his professional domain defines what the briefing characterises as the weakest federal public-health roster of the post-2014 era.